Mahlangu, J. N., Ahuja, S. P., Windyga, J., Church, N., Shah, A., & Schwartz, L. (2018). BAY 81-8973, a full-length recombinant factor VIII for the treatment of hemophilia A: Product review. Ther Adv Hematol.

Mahlangu, Johnny N., Sanjay P. Ahuja, Jerzy Windyga, Nikki Church, Anita Shah, and Lawrence Schwartz. "BAY 81-8973, a Full-length Recombinant Factor VIII for the Treatment of Hemophilia A: Product Review." Ther Adv Hematol 2018.

Mahlangu, Johnny N., et al. "BAY 81-8973, a Full-length Recombinant Factor VIII for the Treatment of Hemophilia A: Product Review." Ther Adv Hematol 2018.